Cargando…

Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics

OBJECTIVE: This study elucidates the potential therapeutic targets and molecular mechanisms of KTC in the treatment of PCOS. MATERIALS AND METHODS: Using the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP), the active ingredients and potential targets of KTC w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiushen, Ma, Jingxin, Guo, Li, Dong, Chenle, Zhu, Guli, Hong, Wenli, Chen, Can, Wang, Hao, Wu, Xueqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073551/ https://www.ncbi.nlm.nih.gov/pubmed/35528524 http://dx.doi.org/10.1155/2022/3145938

Ejemplares similares

Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
por: Liang, Ruining, et al.
Publicado: (2019)

Identification of the active ingredients and pharmacological effects of Kuntai capsules in the treatment of primary ovarian insufficiency: A review
por: Liu, Feng-Xia, et al.
Publicado: (2023)

Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model
por: Zhong, Ruihua, et al.
Publicado: (2016)

Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis
por: Ma, Qianwen, et al.
Publicado: (2020)

Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function
por: Lin, Xin-Miao, et al.
Publicado: (2021)

The effect of Kuntai capsule on ovarian function in cisplatin-induced premature ovarian insufficiency rats
por: Luo, Suiyu, et al.
Publicado: (2023)

The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
por: Zhang, Shuzhen, et al.
Publicado: (2021)

Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data
por: Hou, Yan, et al.
Publicado: (2019)

Kuntai Capsule Combined With Letrozole on Gonadal Hormone Levels and Ovarian Function in Patients With PCOS: A Systematic Review and Meta-Analysis
por: Tang, Xing, et al.
Publicado: (2021)

Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis
por: Liu, Weiping, et al.
Publicado: (2019)

Corrigendum to “Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis”
por: Liu, Weiping, et al.
Publicado: (2021)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis
por: Zeng, Zhi, et al.
Publicado: (2020)

Bioinformatics searching of diagnostic markers and immune infiltration in polycystic ovary syndrome
por: Yao, Xinrui, et al.
Publicado: (2022)

Exploring the relationship between osteoporosis and polycystic ovary syndrome based on bioinformatics
por: Dang, Chun-xiao, et al.
Publicado: (2022)

Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome
por: Xing, Jinshan, et al.
Publicado: (2023)

Efficacy and Safety Investigation of Kuntai Capsule for the Add-back Therapy of Gonadotropin Releasing Hormone Agonist Administration to Endometriosis Patients: A Randomized, Double-blind, Blank- and Tibolone-controlled Study
por: Chen, Ji-Ming, et al.
Publicado: (2015)

Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model
por: Lian, Yuling, et al.
Publicado: (2020)

Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome
por: Wang, Wenqi, et al.
Publicado: (2022)

Effective Material Basis and Mechanism Analysis of Compound Banmao Capsule against Tumors Using Integrative Network Pharmacology and Molecular Docking
por: He, Tian-Mu, et al.
Publicado: (2021)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
por: Zou, Juan, et al.
Publicado: (2022)

Identification of Three Potential circRNA Biomarkers of Polycystic Ovary Syndrome by Bioinformatics Analysis and Validation
por: Huang, Pengyu, et al.
Publicado: (2021)

Identification of immune cell infiltration and effective biomarkers of polycystic ovary syndrome by bioinformatics analysis
por: Gao, Mengge, et al.
Publicado: (2023)

Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises
por: Akter, Tanzina, et al.
Publicado: (2023)

Bioactive NIR‐II Light‐Responsive Shape Memory Composite Based on Cuprorivaite Nanosheets for Endometrial Regeneration
por: Dong, Chenle, et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
por: Devarbhavi, Praveenkumar, et al.
Publicado: (2021)

Effect of chamomile capsule on lipid- and hormonal-related parameters among women of reproductive age with polycystic ovary syndrome
por: Heidary, Maryam, et al.
Publicado: (2018)

A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
por: Liu, Lihong, et al.
Publicado: (2018)

Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
por: Wang, Yu, et al.
Publicado: (2016)

Prevention of polycystic ovary syndrome and postmenopausal osteoporosis by inhibiting apoptosis with Shenling Baizhu powder compound
por: Liang, Jing, et al.
Publicado: (2022)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Effect of Aslagh Capsule, a Traditional Compound Herbal Product on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Three-Arm, Open-label, Randomized, Controlled Trial
por: Bahman, Maryam, et al.
Publicado: (2019)

Changes in the prevalence of polycystic ovary syndrome in China over the past decade
por: Yang, Rui, et al.
Publicado: (2022)

Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA
por: Pant, Pankaj, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mthqnnl3bjp2ugch98bgsj1s17